When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 15 Dec 2023

Summary

Definition

History and exam

Key diagnostic factors

  • flank pain
  • costovertebral angle tenderness
  • fever
  • new or different myalgia, or flu-like symptoms
  • presence of risk factors
  • nausea
  • vomiting

Other diagnostic factors

  • suprapubic tenderness
  • tachycardia
  • hypotension

Risk factors

  • urinary tract infection
  • diabetes mellitus
  • stress incontinence
  • foreign body in urinary tract (e.g., calculus, catheter)
  • anatomical/functional urinary abnormality
  • immunosuppressive state (e.g., HIV, transplantation, chemotherapy, corticosteroid use)
  • pregnancy
  • frequent sexual intercourse
  • mother with urinary tract infection history
  • new sex partner
  • spermicide use
  • age between 18 and 50 years
  • age >60 years

Diagnostic investigations

1st investigations to order

  • urinalysis
  • urine culture and sensitivity
  • full blood count
  • erythrocyte sedimentation rate
  • C-reactive protein
  • urea and electrolytes
  • creatinine
  • blood culture (in hospital)

Investigations to consider

  • renal ultrasound
  • contrast-enhanced CT
  • MRI

Treatment algorithm

Contributors

Expert advisers

Andrew Lewington, BSc (Hons), MBBS, MEd, MD, FRCP

Consultant Renal Physician

Honorary Associate Professor

Nephrology Department

Leeds Teaching Hospitals NHS Trust

Head of MBChB

School of Medicine

University of Leeds

Leeds

UK

Disclosures

AL has been the principal applicant/co-applicant for a number of grants including: Engineering and Physical Sciences Research Council Research - Multiplexed AKI biomarker detection with a single molecule biosensor; Leeds Cares - A novel, non-invasive diagnostic approach to assess kidney transplant health through the targeted measurement of biomarkers of kidney injury and immune response in kidney transplant recipients at the Leeds Teaching Hospitals NHS Trust; Kidney Research Yorkshire - Use of enhanced technology to characterise haemodialysis treatment for acute kidney injury (AKI); Bringing It Home - Validation of a micro-sampling technique for measuring tacrolimus and creatinine remotely; and to fund a research nurse; British Renal Society - Renal function assessment with point of care creatinine in diverse populations (RAPID), and several NIHR grants including on a) Improving the quality of post-discharge care following AKI b) An investigation into the use of remote blood sample collection to reduce health inequalities in patients with mental health disorders c) A comparison of remote blood collection devices: a human factor use study d) Defining the characteristics for a novel automatic device to monitor urine output in catheterized patients e) Leeds Medtech and In-vitro Diagnostic Cooperative Grant Extension f) Surgical MedTech Co-operative for the 2019/20 proof-of-principle funding stream g) A pilot investigation into the use of beta-trace protein for residual renal function estimation in haemodialysis h) Application of functional MRI to improve assessment of chronic kidney disease (AFiRM study) i) SuperResPath-Renal: Quantitative super-resolution technology for a fast, decentralised clinical diagnosis of renal pathologies. AL is the co-author of a number of manuscripts including on extracorporeal treatments, AKI, kidney function testing prior to contrast-enhanced CT, plasma exchange and glucocorticoids in severe ANCA-associated vasculitis, COVID-19 rapid diagnostics, multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome, and on a summary of NICE guidance on CKD. AL is the author of several book chapters on nephrology and AKI. AL has received expenses for accommodation and travel for conferences at which he has given lectures, other than those delivered virtually. AL was a member of the AKI Scientific Program Committee for the ISN World Congress of Nephrology 2020-2021 and Chair of this same committee in 2021-2022.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributor, whose work has been retained in parts of the content:

Lynda A. Frassetto, MD

Professor of Medicine

Division of Nephrology

University of California

San Francisco

CA

LAF declares that she has no competing interests.

Peer reviewers

Shruti Goel, MBBS, FRCP

Consultant Nephrologist

The Hillingdon Hospital NHS Foundation Trust

London

UK

Disclosures

SG declares that she has no competing interests.

Use of this content is subject to our disclaimer